Adolesan Kontrasepsiyon

Adolesan dönem çocukluktan erişkinliğe geçiş dönemi olduğu için kendine has sorunları ve çatışmaları barındırır. Bu sorunlardan birisi de cinsel olarak aktif olmaya başlayan bireyin cinsellik sonucunda karşılaşabileceği problemlerdir. Adolesan dönemde kontrasepsiyon insidansı yetişkin dönem ile karşılaştırıldığında oldukça düşüktür ve ülkelere göre farklılıklar göstermektedir. Adolesan dönemin kendine has özellikleri düşünülerek kontrasepsiyon planının belirlenmesi adolesan sağlığı açısından son derece büyük bir önem taşır.

Adolescent Contraception

Adolescent period can be described as a transition period from childhood to adulthood. This period contains unique problems and conflicts. One of these problems is encountering sexual problems of sexually active adolescent. Contraception incidence is considerably low in adolescent period when compared to adulthood and differences can be recognized between countries. If specific features of adolescent period are going to be considered, defining a contraception plan is seemed to be extremely important for public health issues.

___

  • Abma JC, Martinez GM, Copen CE. Teenagers in the United States: sexu- al activity, contraceptive use, and childbearing, National Survey of Family Growth 2006–2008. National Center for Health Statistics. Vital Health Statics 2010; 23:1–47.
  • National Youth Risk Behavior Survey: 1991–2005. Trends in the preva- lence of sexual behaviors.
  • Facts on American teen’s sexual and reproductive health. Guttmacher Institute. February 2013
  • De Noon D. A History of Birth Control. http://www.medicinenet.com/sc- ript/main/art.asp?articlekey=51170, 4.4.2012
  • French RS,Cowan FM. Contraception for adolescents. Best Practice Re- search Clinical Obstetrics Gynaecology 2009;23:233-47
  • Shrier L. Sexually transmitted diseases in adolescents: biological, cogni- tive, psychological, behavioural and social issues. Adolescence Medical Clinicals 2004;15:215-34.
  • Frost JJ, Darroch JE. Factors associated with contraceptive choice and inconsistent method use, United States, 2004. Perspectives in Sexuality and Reproductive Health 2008; 40:94.
  • ACOG Commitee opinnion on adolescence Contraception and Adoles- cents Pediatrics No: 392 December 2007.
  • Polaneczky. Adolescent contraception. M.Curr Opin Obstet Gynecol. 1998;10:213-9.
  • Beach RK. Contraception in adolescents. Adolescent Health Uptade 1995; 7:2.
  • Feucht C, Vanden Bussche H. Pharmacology update in adolescents: contraception and human papillomavirus vaccination. Adolescent Medi- cal State Art Review 2013;24:57-89.
  • Lawrie TA, Helmerhorst FM, Maitra NK, Kulier R, Bloemenkamp K, Gül- mezoglu AM. Types of progestogens in combined oral contraception: ef- fectiveness and side-effects (Review). Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD004861.
  • Sitruk-Ware R. Progestogens in hormonal replacement therapy: new mo- lecules, risks, and benefits. Menopause 2002;9:6-15.
  • Ahrendt HJ, Adolf D, Buhling KJ. Advantages and challenges of oest- rogen-free hormonal contraception. Current Medical Research Opinions 2010;26:1947-1955.
  • Cromer BA Depo-Provera- wherefore art thou? Adolescent Pediatric Gy- necology 1992;5:155-62.